Solein is a versatile ingredient: thanks to its mild taste, products made with Solein can taste like anything Solein Protein ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

CEO Stephen Glover said, “ZyVersa is developing Cholesterol Efflux Mediator VAR 200 for treatment of chronic kidney diseases, initially ...

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across ...

The findings build on previous work from the research team demonstrating that LMHR individuals have similar levels of coronary plaque to a carefully-matched comparison group with normal LDL levels, ...

The number of people living with dementia, including Alzheimer’s, is expected almost to double every 20 years.

Lower LDL-C levels were associated with a reduced risk of all-cause dementia and ADRD at 26% and 28%, respectively, as compared to higher LDL-C levels. LDL-C levels below 55 mg/dL or 1.4 mmol/L were ...